Manager/Sr Manager, Financial Planning and Analysis jobs in United States
cer-icon
Apply on Employer Site
company-logo

Esperion · 2 hours ago

Manager/Sr Manager, Financial Planning and Analysis

Esperion is a fully remote based company with a corporate headquarters located in Ann Arbor, MI, focused on delivering innovative medicines. The Manager/Senior Manager, Financial Planning and Analysis will act as a financial business partner, providing financial analysis, operations planning, forecasting, and collaborating with cross-functional teams to maximize performance.

BiotechnologyHealth CareMedicalPharmaceutical

Responsibilities

Partner with all areas of the assigned business unit(s) to prepare annual budget and long-range operating plan
Act as a trusted financial advisor to the assigned business unit(s) executive management and their leadership teams
Liaise with the assigned business unit(s) to identify and prioritize cost savings initiatives
Provide ad-hoc analyses and other project support to the assigned business unit(s) leadership teams
Provide guidance and analysis to support clinical trials and development opportunities. This includes representing finance in cross functional reviews to recommend profitable use of resources, NPV/ROI analysis for clinical opportunities, etc
Manage the financial aspects of the clinical trial portfolio
Partner with Technical Accounting and Procurement to analyze and influence complex clinical/research contract proposals
Partner with the Controller function on aspects of the monthly and quarterly close process, including managing expense accruals, management reporting, and budget vs. actual variance analysis. Prepare and present results to assigned business unit(s), Finance, and executive leadership
Provide financial expertise to the assigned business unit(s) on vendor selection
Challenge and develop current process and methodologies and push for improvement to increase the efficiency and effectiveness of our reporting and analysis
Support the enterprise on financial process improvement projects including ERP implementation as well as recommend and drive continuous improvements to financial processes
Manage aspects of commercial revenue forecasting and tracking actuals vs. forecast
Manage aspects of the collaboration royalty revenue process
Prepare quarterly financial reporting deliverables for the Executive Leadership Team and Board of Directors

Qualification

FP&A experienceFinancial modelingUS GAAP knowledgeMBACPAMicrosoft Excel proficiencyFinancial analysisCommunication skillsLeadership skillsCollaboration skillsProblem-solving skills

Required

Bachelor's Degree in Finance, Accounting, or related field
Minimum 5 years' finance experience with increasing levels of responsibility
FP&A experience with commercial bio-tech or pharmaceutical organization, including experience supporting R&D, Technical Operations, and/or Commercial organizations is required
10% domestic travel is required
Comfortable with communicating, presenting, and influencing at the executive level
In-depth proficiency in aspects of accounting/finance and knowledge of US GAAP is required
In depth knowledge of US Healthcare Systems, Business Intelligence, Planning and ERP systems is required
Proficiency in Microsoft Office products, including demonstrated experience using Excel to build and maintain complex financial models as well as perform financial and data analysis

Preferred

MBA and/or CPA preferred
Experience in a high-growth, global organization a plus
Experience leading financial reporting, financial analysis, and budgeting processes

Benefits

Performance-based bonus program
Stock-based compensation
Comprehensive benefits package
401(k) matching plan
Health insurance
Paid time off
Holidays

Company

Esperion

twittertwittertwitter
company-logo
Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.

Funding

Current Stage
Public Company
Total Funding
$1.18B
Key Investors
Athyrium Capital Management LPOberland CapitalLongitude Capital
2025-10-07Post Ipo Equity· $75M
2024-12-13Post Ipo Debt· $250M
2024-01-18Post Ipo Equity· $97.8M

Leadership Team

leader-logo
Sheldon Koenig
President and CEO of Esperion Therapeutics
linkedin
leader-logo
John Harlow
Chief Commercial Officer
linkedin
Company data provided by crunchbase